The FDA granted full approval for Symvess on December 19, 2024, for use as a vascular conduit in adults requiring urgent revascularization to prevent limb loss when an autologous vein graft is not an ...

Cipla share price: In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib capsules in 50 mg, 150 mg, and 200 mg strengths. The oral ...

Jim Jones, the director of the Food and Drug Administration’s food division, resigned on Monday, citing what he called “indiscriminate” layoffs that would make it “fruitless for him to ...

The company is recalling the product as "N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit". The company initiated the Class II recall on January 22 ...

Probationary employees across the FDA received notices Saturday evening that their jobs were being eliminated, according to three FDA staffers who spoke to The Associated Press on condition of ...

Email: [email protected] President Donald Trump administration's push to downsize the federal government has reached the U.S. Food and Drug Administration (FDA), resulting in layoffs that ...

Dr. Frances O. Kelsey, pictured here in the 1960s, spent most of her career at the FDA overseeing scientific investigations of drugs. It was an application from William S. Merrell, an Ohio ...

Fish unloaded in the country’s regional ports shrank by 12.09 percent year-on-year in the fourth quarter of 2024, according to the Philippine Fisheries Development Authority (PFDA). In its ...

“By the end of this quarter, the two trials would be concluded and then the application for approval will be sent to the FDA,” de Mesa said. He noted that the vaccines undergoing field trials ...

Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.

Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.